Exhibit 24
Information Regarding Joint Filers
Designated Filer of Form 4: Ardsley Advisory Partners LP
Date of Earliest Transaction Required to be Reported: November 5, 2019
Issuer Name and Ticker Symbol:Sunopta Inc. (STKL)
| Names: | Ardsley Advisory Partners LP, Ardsley Advisory Partners GP LLC, Ardsley Partners I GP LLC, Philip J. Hempleman, Ardsley Partners Renewable Energy Fund, L.P., Ardsley Healthcare Fund, L.P., Ardsley Partners Duckdive Fund, L.P., Ardsley Ridgecrest Partners, L.P. |
| Address: | Ardsley Advisory Partners LP 262 Harbor Drive, 4th Floor Stamford, CT 06902 |
Signatures:
The undersigned, Ardsley Advisory Partners LP, Ardsley Advisory Partners GP LLC, Ardsley Partners I GP LLC, Phillip Hempleman, Ardsley Partners Renewable Energy Fund, L.P., Ardsley Healthcare Fund, L.P., Ardsley Partners Duckdive Fund, L.P., and Ardsley Ridgecrest Partners, L.P. are jointly filing the attached Statement of Changes in Beneficial Ownership of Securities on Form 4 with respect to the beneficial ownership of securities of Sunopta Inc.
ARDSLEY ADVISORY PARTNERS LP
By: Ardsley Advisory Partners GP LLC, its General Partner
/s/ Steve Napoli
By: Steve Napoli, Partner
ARDSLEY ADVISORY PARTNERS GP LLC
/s/ Steve Napoli
By: Steve Napoli, Partner
ARDSLEY PARTNERS I GP LLC
/s/ Steve Napoli
By: Steve Napoli, Partner
PHILIP J. HEMPLEMAN
By: Steve Napoli/Attorney-in-Fact for Philip J. Hempleman
/s/ Steve Napoli*
By: Steve Napoli
ARDSLEY HEALTHCARE FUND, L.P.
By: Ardsley Partners I GP LLC, General Partner
/s/ Steve Napoli
By: Steve Napoli, Partner
ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.
By: Ardsley Partners I GP LLC, General Partner
/s/ Steve Napoli
By: Steve Napoli, Partner
ARDSLEY DUCKDIVE FUND, L.P.
By: Ardsley Partners I GP LLC, General Partner
/s/ Steve Napoli
By: Steve Napoli, Partner
ARDSLEY RIDGECREST PARTNERS FUND, L.P.
By: Ardsley Partners I GP LLC, General Partner
/s/ Steve Napoli
By: Steve Napoli, Partner
* Executed by Steve Napoli as Attorney-in-Fact for Philip J. Hempleman. The Power of Attorney for Mr. Hempleman is attached as Exhibit 2 to the Statement on Schedule 13G/A with respect to the Common Stock of Vaxgen, Inc., filed on February 15, 2006, and is incorporated herein by reference.